Literature DB >> 21865098

CGK733 does not inhibit ATM or ATR kinase activity in H460 human lung cancer cells.

Serah Choi, Luis I Toledo, Oscar Fernandez-Capetillo, Christopher J Bakkenist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21865098      PMCID： PMC3189494          DOI： 10.1016/j.dnarep.2011.07.013

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN： 1568-7856


× No keyword cloud information.
  15 in total

1.  ATM is the predominant kinase involved in the phosphorylation of histone H2AX after heating.

Authors:  Akihisa Takahashi; Eiichiro Mori; Xiaoming Su; Yosuke Nakagawa; Noritomo Okamoto; Hirokazu Uemura; Natsuko Kondo; Taichi Noda; Atsushi Toki; Yosuke Ejima; David J Chen; Ken Ohnishi; Takeo Ohnishi
Journal:  J Radiat Res       Date:  2010-04-24       Impact factor: 2.724

2.  Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.

Authors:  Ian Hickson; Yan Zhao; Caroline J Richardson; Sharon J Green; Niall M B Martin; Alisdair I Orr; Philip M Reaper; Stephen P Jackson; Nicola J Curtin; Graeme C M Smith
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

3.  DNA-PKcs and ATM co-regulate DNA double-strand break repair.

Authors:  Meena Shrivastav; Cheryl A Miller; Leyma P De Haro; Stephen T Durant; Benjamin P C Chen; David J Chen; Jac A Nickoloff
Journal:  DNA Repair (Amst)       Date:  2009-06-16

4.  Small molecule-based reversible reprogramming of cellular lifespan.

Authors:  Jaejoon Won; Mina Kim; Nuri Kim; Jin Hee Ahn; Woo Gil Lee; Sung Soo Kim; Ki-Young Chang; Yong-Weon Yi; Tae Kook Kim
Journal:  Nat Chem Biol       Date:  2006-06-11       Impact factor: 15.040

5.  Transient ATM kinase inhibition disrupts DNA damage-induced sister chromatid exchange.

Authors:  Jason S White; Serah Choi; Christopher J Bakkenist
Journal:  Sci Signal       Date:  2010-06-01       Impact factor: 8.192

6.  Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.

Authors:  Sandra Cuffe; Catherine M Dowling; James Claffey; Clara Pampillón; Megan Hogan; John M Fitzpatrick; Michael P Carty; Matthias Tacke; R William G Watson
Journal:  Prostate       Date:  2011-02-01       Impact factor: 4.104

7.  Enhanced DNA-PK-mediated RPA2 hyperphosphorylation in DNA polymerase eta-deficient human cells treated with cisplatin and oxaliplatin.

Authors:  Séverine Cruet-Hennequart; Macdara T Glynn; Laura S Murillo; Seamus Coyne; Michael P Carty
Journal:  DNA Repair (Amst)       Date:  2008-03-04

8.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

Authors:  S Matsuoka; M Huang; S J Elledge
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

9.  Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.

Authors:  Sarah E Golding; Elizabeth Rosenberg; Nicholas Valerie; Isa Hussaini; Mark Frigerio; Xiaoling F Cockcroft; Wei Yee Chong; Marc Hummersone; Laurent Rigoreau; Keith A Menear; Mark J O'Connor; Lawrence F Povirk; Timothy van Meter; Kristoffer Valerie
Journal:  Mol Cancer Ther       Date:  2009-10-06       Impact factor: 6.261

10.  The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation.

Authors:  John P Alao; Per Sunnerhagen
Journal:  Radiat Oncol       Date:  2009-11-10       Impact factor: 3.481
View more
  7 in total

1.  The heterogenic final cell cycle of chicken retinal Lim1 horizontal cells is not regulated by the DNA damage response pathway.

Authors:  Shahrzad Shirazi Fard; Charlotta All-Ericsson; Finn Hallböök
Journal:  Cell Cycle       Date:  2013-11-18       Impact factor: 4.534

2.  The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity.

Authors:  Jayashree Thatte; Paola Massimi; Miranda Thomas; Siaw Shi Boon; Lawrence Banks
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

Review 3.  ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells.

Authors:  Cyril Ronco; Anthony R Martin; Luc Demange; Rachid Benhida
Journal:  Medchemcomm       Date:  2016-11-30       Impact factor: 3.597

Review 4.  Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising.

Authors:  Christian Jekimovs; Emma Bolderson; Amila Suraweera; Mark Adams; Kenneth J O'Byrne; Derek J Richard
Journal:  Front Oncol       Date:  2014-04-22       Impact factor: 6.244

5.  From yeast to humans: Understanding the biology of DNA Damage Response (DDR) kinases.

Authors:  José Renato Rosa Cussiol; Bárbara Luísa Soares; Francisco Meirelles Bastos de Oliveira
Journal:  Genet Mol Biol       Date:  2019-12-13       Impact factor: 1.771

6.  APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.

Authors:  Hiroyuki Yamazaki; Kotaro Shirakawa; Tadahiko Matsumoto; Yasuhiro Kazuma; Hiroyuki Matsui; Yoshihito Horisawa; Emani Stanford; Anamaria Daniela Sarca; Ryutaro Shirakawa; Keisuke Shindo; Akifumi Takaori-Kondo
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

7.  Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities.

Authors:  Kumar Sanjiv; Anna Hagenkort; José Manuel Calderón-Montaño; Tobias Koolmeister; Philip M Reaper; Oliver Mortusewicz; Sylvain A Jacques; Raoul V Kuiper; Niklas Schultz; Martin Scobie; Peter A Charlton; John R Pollard; Ulrika Warpman Berglund; Mikael Altun; Thomas Helleday
Journal:  Cell Rep       Date:  2015-12-31       Impact factor: 9.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.